Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 3
2005 2
2006 2
2007 1
2009 1
2010 1
2018 1
2020 1
2021 1
2022 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Genetic and immune landscape evolution in MMR-deficient colorectal cancer.
Challoner BR, Woolston A, Lau D, Buzzetti M, Fong C, Barber LJ, Anandappa G, Crux R, Assiotis I, Fenwick K, Begum R, Begum D, Lund T, Sivamanoharan N, Sansano HB, Domingo-Arada M, Tran A, Pandha H, Church D, Eccles B, Ellis R, Falk S, Hill M, Krell D, Murugaesu N, Nolan L, Potter V, Saunders M, Shiu KK, Guettler S, Alexander JL, Lázare-Iglesias H, Kinross J, Murphy J, von Loga K, Cunningham D, Chau I, Starling N, Ruiz-Bañobre J, Dhillon T, Gerlinger M. Challoner BR, et al. Among authors: dhillon t. J Pathol. 2024 Feb;262(2):226-239. doi: 10.1002/path.6228. Epub 2023 Nov 15. J Pathol. 2024. PMID: 37964706
Paclitaxel for AIDS-associated Kaposi's sarcoma.
Dhillon T, Stebbing J, Bower M. Dhillon T, et al. Expert Rev Anticancer Ther. 2005 Apr;5(2):215-9. doi: 10.1586/14737140.5.2.215. Expert Rev Anticancer Ther. 2005. PMID: 15877519 Review.
Bile Microbiome Signatures Associated with Pancreatic Ductal Adenocarcinoma Compared to Benign Disease: A UK Pilot Study.
Merali N, Chouari T, Terroire J, Jessel MD, Liu DSK, Smith JH, Wooldridge T, Dhillon T, Jiménez JI, Krell J, Roberts KJ, Rockall TA, Velliou E, Sivakumar S, Giovannetti E, Demirkan A, Annels NE, Frampton AE. Merali N, et al. Among authors: dhillon t. Int J Mol Sci. 2023 Nov 28;24(23):16888. doi: 10.3390/ijms242316888. Int J Mol Sci. 2023. PMID: 38069211 Free PMC article.
Cardiotoxicity after liposomal anthracyclines.
Young AM, Dhillon T, Bower M. Young AM, et al. Among authors: dhillon t. Lancet Oncol. 2004 Nov;5(11):654. doi: 10.1016/S1470-2045(04)01605-5. Lancet Oncol. 2004. PMID: 15522651 No abstract available.
PRIME-HCC: phase Ib study of neoadjuvant ipilimumab and nivolumab prior to liver resection for hepatocellular carcinoma.
Pinato DJ, Cortellini A, Sukumaran A, Cole T, Pai M, Habib N, Spalding D, Sodergren MH, Martinez M, Dhillon T, Tait P, Thomas R, Ward C, Kocher H, Yip V, Slater S, Sharma R. Pinato DJ, et al. Among authors: dhillon t. BMC Cancer. 2021 Mar 23;21(1):301. doi: 10.1186/s12885-021-08033-x. BMC Cancer. 2021. PMID: 33757459 Free PMC article. Clinical Trial.
Rationale and design of the POLEM trial: avelumab plus fluoropyrimidine-based chemotherapy as adjuvant treatment for stage III mismatch repair deficient or POLE exonuclease domain mutant colon cancer: a phase III randomised study.
Lau D, Kalaitzaki E, Church DN, Pandha H, Tomlinson I, Annels N, Gerlinger M, Sclafani F, Smith G, Begum R, Crux R, Gillbanks A, Wordsworth S, Chau I, Starling N, Cunningham D, Dhillon T. Lau D, et al. Among authors: dhillon t. ESMO Open. 2020 Feb;5(1):e000638. doi: 10.1136/esmoopen-2019-000638. ESMO Open. 2020. PMID: 32079623 Free PMC article. Clinical Trial.
16 results